# Efficacy and Safety of Dexmedetomidine in the Analgesic Prophylaxis , in Patients Undergoing Cardiovascular Surgery

Study · id `cardio:ct-nct05079672` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05079672](<https://clinicaltrials.gov/study/NCT05079672>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05079672

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Valve and congenital heart disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 102 participants.

## Technical summary

Registry record NCT05079672. Randomized; double masking; primary purpose prevention. Start 2021-10-07 (actual); primary completion 2022-10-10 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 102 participants (planned count; ClinicalTrials.gov record NCT05079672, source copy `cardio:ctgov-nct05079672-2021-10-20`, retrieved 2026-10-26)
- Started: 2021-10-07 (actual) (ClinicalTrials.gov record NCT05079672, source copy `cardio:ctgov-nct05079672-2021-10-20`, retrieved 2026-10-26)
- Primary completion: 2022-10-10 (anticipated) (ClinicalTrials.gov record NCT05079672, source copy `cardio:ctgov-nct05079672-2021-10-20`, retrieved 2026-10-26)
- Completion: 2023-10-10 (anticipated) (ClinicalTrials.gov record NCT05079672, source copy `cardio:ctgov-nct05079672-2021-10-20`, retrieved 2026-10-26)
- Countries: Brazil (ClinicalTrials.gov record NCT05079672, source copy `cardio:ctgov-nct05079672-2021-10-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05079672-2021-10-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy and Safety of Dexmedetomidine in the Analgesic Prophylaxis , in Patients Undergoing Cardiovascular Surgery
- Condition: Cardiopathy
- Condition: Coronary Artery Disease
- Condition: Valve Heart Disease
- Condition: Pain
- Intervention (Drug): Dexmedetomidine
- Intervention (Drug): 0,9% Saline
- Lead sponsor: University of Sao Paulo
- Lead sponsor class: OTHER
- Collaborator: Federal University of Paraíba
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: University of Sao Paulo (`cardio:org-university-of-sao-paulo`)

## Provenance

Content hash: 11ae57fa63ae984922afdb3e8203165e0039ab3ee167df3ae9e200d639999ff6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
